Annie Yoshiyama - Jun 5, 2024 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
SVP, Finance
Signature
/s/Annie Yoshiyama
Stock symbol
ALLO
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
3
Date filed
6/11/2024, 04:10 PM
Previous filing
Aug 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALLO Common Stock 102K Jun 5, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALLO Stock Option (Right to buy) Jun 5, 2024 Common Stock 349K $3.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting, 1/4th of the RSUs will vest on April 20th, 2025 and the remainder will vest annually thereafter.
F2 25% of the shares subject to the stock option shall vest on April 8, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter.